Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

Item
http://www.wikidata.org/entity/Q34732964
High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002Sins of omission: getting too little medical care may be the greatest threat to patient safety.Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetesACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study).The impact of disadvantage on the development and progression of diabetic kidney disease.CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC StudiesPatients with multiple chronic conditions do not receive lower quality of preventive careACE inhibitor and ARB medication use among Medicaid enrollees with diabetesUtilization of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in patients diagnosed with diabetes: Analysis from the National Ambulatory Medical Care SurveyReceipt of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers among Medicare Beneficiaries with Diabetes and HypertensionA Comparison of the Use of Clinical-Guideline-Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012.The place for ACE inhibitors.Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
P2860

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

Item
http://www.wikidata.org/entity/Q34732964
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@ast
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@en
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@nl
type
label
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@ast
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@en
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@nl
prefLabel
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@ast
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@en
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Use of angiotensin-converting ...... d ethnic groups with diabetes.
@en
P2093
P2860
P2888
P304
P31
P356
10.1111/J.1525-1497.2004.30264.X
P433
P478
P577
P5875
P6179
P698
P932